Hironobu Minami - Concepedia

Author

Hironobu Minami

National Cancer Center Hospital East ORCID

Also Known As

H Minami, H. Minami, H., Minami, HIRONOBU MINAMI, Hirofumi Taji, Hironobu MINAMI, Hironobu Minami, Hitomi Minami, Minami Hironobu, Y Ando

695

Publications

15K

Citations

H-Index

173

Concepts

All Affiliations

National Cancer Center Hospital East Kobe University Hospital Kobe University National Institute of Health Sciences Tokyo National Hospital

About

Hironobu Minami is an author at National Cancer Center Hospital East specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	94	3.6K
2	Health Sciences	17	24	934
3	Engineering	2	2	48
4	Public Health	2	2	38
5	Biochemistry	2	2	85

Hironobu Minami

217

Publications

13.6K

Citations

H-Index

Page 1

	Year	Citations
Peroral endoscopic myotomy (POEM) for esophageal achalasia Haruhiro Inoue, Hironobu Minami, Yasutoshi Kobayashi, Endoscopy	2010	1.8K
Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer Yoshinori Imamura, Toru Mukohara, Yohei Shimono, Oncology Reports	2015	834
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS Takayuki Yoshino, Dirk Arnold, Hiroya Taniguchi, Annals of Oncology	2017	576
Zoledronic Acid Significantly Reduces Skeletal Complications Compared With Placebo in Japanese Women With Bone Metastases From Breast Cancer: A Randomized, Placebo-Controlled Trial Norio Kohno, Kenjiro Aogi, Hironobu Minami, Journal of Clinical Oncology	2005	545
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure Timothy P. Hughes, Michael J. Mauro, Jörge E. Cortes, New England Journal of Medicine	2019	449
ROLE OF ORGANIC ANION TRANSPORTER OATP1B1 (OATP-C) IN HEPATIC UPTAKE OF IRINOTECAN AND ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN: IN VITRO EVIDENCE AND EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMS Takashi Nozawa, Hironobu Minami, Shigeki Sugiura, Drug Metabolism and Disposition	2004	313
Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A16 and 28 Hironobu Minami, Kimie Sai, Mayumi Saeki, Pharmacogenetics and Genomics	2007	285
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS Kei Muro, Florian Lordick, Takahiro Tsushima, Annals of Oncology	2018	284
Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines Yu Kataoka, Toru Mukohara, Hiroyuki Shimada, Annals of Oncology Breast OncologyHer2-targeted AgentsMedicineCancer GenomicsBreast Cancer	2009	233
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS Kei Muro, Eric Van Cutsem, Yukiya Narita, Annals of Oncology	2018	214

Page 1